Can a simple supplement slow Parkinson's decline?
NCT ID NCT07064005
Summary
This small, early-stage study is testing whether taking an oral supplement called gamma-glutamylcysteine (GGC) can help people with early Parkinson's disease. Researchers want to see if GGC boosts a key brain antioxidant, which might help control movement problems and thinking skills. The study will also check if the supplement affects gut health.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSONS DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UPMC Presbyterian Hospital
Pittsburgh, Pennsylvania, 15213, United States
Conditions
Explore the condition pages connected to this study.